Estate Counselors’s Royalty Pharma RPRX Stock Holding History

Estate Counselors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,740	Closed	-$1.02M	–	160
2022 Q4	$1.02M	Buy	25,740 +150	+0.6%	+$6.26K	0.14%	104
2022 Q3	$1.03M	Hold	25,590	–	–	0.16%	80
2022 Q2	$1.07M	Buy	+25,590	New	+$1.05M	0.16%	82

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Estate Counselors's RPRX Position: Q1 2023 in Review

Estate Counselors sold out of Royalty Pharma (RPRX) in Q1 2023, closing a stake of 25,740 shares — an estimated $1.02M sold.

Estate Counselors first reported a position in RPRX in Q2 2022 and held it in 3 quarters. The position peaked at $1.07M in Q2 2022. 335 funds tracked by Wall St. Rank hold RPRX as of Q1 2023.

Estate Counselors reported no remaining Royalty Pharma position as of Q1 2023 after selling out during the quarter.
Estate Counselors sold 25,740 Royalty Pharma shares in Q1 2023, an estimated $1.02M.
Estate Counselors first reported a position in Royalty Pharma in Q2 2022 and held it in 3 quarters.
Estate Counselors's Royalty Pharma position peaked at $1.07M in Q2 2022.
335 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2023.

Based on Estate Counselors's 13F filing for Q1 2023, filed 4 May 2023.